US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist

44.480
+0.930+2.14%

Close Feb 28 16:00 ET

44.480
0.0000.00%

Post 20:01 ET

1.71BMarket Cap-14.49P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tarsus Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 25, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	58.80M	66.41M	+7.60M
Beat Est.	+349.70%	+407.86%	+12.93%
EPS	-0.67	-0.60	+0.07
Beat Est.	+48.53%	+54.20%	+11.01%

Analyst Rating

Strong Buy

Mar 1, 2025

Tarsus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 85.696M	--
--	2025/Q1	-- / 68.866M	--
Feb 25, 2025	2024/Q4	66.408M / 58.803M	--
Nov 13, 2024	2024/Q3	48.118M / 43.177M	--
Aug 8, 2024	2024/Q2	40.813M / 32.048M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 85.696M--

--2025/Q1-- / 68.866M--

Feb 25, 20252024/Q466.408M / 58.803M--

Nov 13, 20242024/Q348.118M / 43.177M--

Aug 8, 20242024/Q240.813M / 32.048M--

Unlock Free Earnings Estimates

Open Account

Tarsus Pharmaceuticals Earnings Reports

Tarsus Pharmaceuticals | 10-K: FY2024 Annual Report

Feb 25 16:09 ET

Tarsus Pharmaceuticals | 8-K: Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Achievements

Feb 25 07:11 ET

Tarsus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 16:18 ET

Tarsus Pharmaceuticals | 8-K: Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

Nov 13, 2024 16:12 ET